Table 4.

INR monitoring during the 1-year follow-up

Categories	1 mo	3 mo	6 mo	9 mo	12 mo	P-value
VASP-guided group	1.8 ± 0.3	2.1 ± 0.5	1.9 ± 0.7	2.0 ± 0.2	2.2 ± 0.4	0.33
Control group	1.7 ± 0.9	2.0 ± 0.3	2.1 ± 0.5	1.9 ± 0.6	2.1 ± 0.2	0.48
CHA2DS2-VASc Score = 1	2.0 ± 0.2	1.7 ± 0.4	2.2 ± 0.9	2.0 ± 0.8	2.1 ± 0.7	0.56
CHA2DS2-VASc Score ≥ 2	1.9 ± 0.3	1.6 ± 0.6	2.3 ± 0.5	2.6 ± 0.9	2.5 ± 0.8	< 0.05
HAS-BLED Score < 2	1.6 ± 0.5	1.8 ± 0.4	2.0 ± 0.6	2.1 ± 0.4	2.2 ± 0.7	0.14
HAS-BLED Score ≥ 3	1.7 ± 0.2	1.9 ± 0.5	2.1 ± 0.6	2.2 ± 0.4	2.1 ± 0.8	0.35

P-value: 1 month vs. 12 months